NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)

The summary for the NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed): Some projects initiated with SBIR or STTR funding require considerable financing beyond the SBIR/STTR Phase II award to achieve commercialization. The development of medical biotechnology products is often impeded by a significant funding gap (known as the Valley of Death) between the end of the SBIR/STTR Phase II award and the commercialization stage. The goal of this FOA is to assist applicants in pursuing the next appropriate milestone(s) necessary to advance a product/technology that requires Federal regulatory approval or to bring a complex research tool to market. This opportunity aims to facilitate the transition of previously funded SBIR and STTR Phase II projects to the commercialization stage by promoting partnerships between NINDS SBIR or STTR awardees and third-party investors and/or strategic partners in the Phase IIB competing renewal. Applicants are strongly encouraged to secure independent third-party funding throughout the Phase IIB project period.
Federal Grant Title: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-24-222
Type of Funding: Grant
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: April 5th, 2027
Original Application Deadline: April 5th, 2027
Posted Date: June 21st, 2024
Creation Date: June 21st, 2024
Archive Date: May 11th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: June 21st, 2024
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-24-222.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Interaction Between Environmental Factors and Lewy Body Dementia (R01 - Clinical Trial Not...
NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition ...
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Indepen...
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Indepen...
NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition ...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial N...
Bridges to the Doctorate Research Training Program (T32)
Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com